16-87644280-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_020655.4(JPH3):c.405C>T(p.Val135Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00287 in 1,610,232 control chromosomes in the GnomAD database, including 89 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 45 hom., cov: 34)
Exomes 𝑓: 0.0018 ( 44 hom. )
Consequence
JPH3
NM_020655.4 synonymous
NM_020655.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.583
Genes affected
JPH3 (HGNC:14203): (junctophilin 3) Junctional complexes between the plasma membrane and endoplasmic/sarcoplasmic reticulum are a common feature of all excitable cell types and mediate cross talk between cell surface and intracellular ion channels. The protein encoded by this gene is a component of junctional complexes and is composed of a C-terminal hydrophobic segment spanning the endoplasmic/sarcoplasmic reticulum membrane and a remaining cytoplasmic domain that shows specific affinity for the plasma membrane. CAG/CTG repeat expansion from normally 6-28 repeats to 40-59 repeats in the 3' UTR of this gene have been associated with Huntington disease-like 2 (HDL2). This gene is a member of the junctophilin gene family. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 16-87644280-C-T is Benign according to our data. Variant chr16-87644280-C-T is described in ClinVar as [Benign]. Clinvar id is 786946.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.583 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0131 (1998/152386) while in subpopulation AFR AF = 0.0436 (1812/41598). AF 95% confidence interval is 0.0419. There are 45 homozygotes in GnomAd4. There are 906 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 1998 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0131 AC: 1993AN: 152268Hom.: 45 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
1993
AN:
152268
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00431 AC: 1044AN: 242420 AF XY: 0.00382 show subpopulations
GnomAD2 exomes
AF:
AC:
1044
AN:
242420
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00180 AC: 2627AN: 1457846Hom.: 44 Cov.: 32 AF XY: 0.00188 AC XY: 1364AN XY: 724920 show subpopulations
GnomAD4 exome
AF:
AC:
2627
AN:
1457846
Hom.:
Cov.:
32
AF XY:
AC XY:
1364
AN XY:
724920
Gnomad4 AFR exome
AF:
AC:
1528
AN:
33438
Gnomad4 AMR exome
AF:
AC:
103
AN:
44504
Gnomad4 ASJ exome
AF:
AC:
2
AN:
25836
Gnomad4 EAS exome
AF:
AC:
0
AN:
39666
Gnomad4 SAS exome
AF:
AC:
586
AN:
85650
Gnomad4 FIN exome
AF:
AC:
7
AN:
52202
Gnomad4 NFE exome
AF:
AC:
172
AN:
1110554
Gnomad4 Remaining exome
AF:
AC:
211
AN:
60242
Heterozygous variant carriers
0
159
317
476
634
793
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0131 AC: 1998AN: 152386Hom.: 45 Cov.: 34 AF XY: 0.0122 AC XY: 906AN XY: 74516 show subpopulations
GnomAD4 genome
AF:
AC:
1998
AN:
152386
Hom.:
Cov.:
34
AF XY:
AC XY:
906
AN XY:
74516
Gnomad4 AFR
AF:
AC:
0.0435598
AN:
0.0435598
Gnomad4 AMR
AF:
AC:
0.00718485
AN:
0.00718485
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0.000192827
AN:
0.000192827
Gnomad4 SAS
AF:
AC:
0.0057947
AN:
0.0057947
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.00030866
AN:
0.00030866
Gnomad4 OTH
AF:
AC:
0.0118147
AN:
0.0118147
Heterozygous variant carriers
0
98
197
295
394
492
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
25
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at